Roll out and prospects of the malaria vaccine R21/Matrix-M.

Seidlein LV.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Roll out and prospects of the malaria vaccine R21/Matrix-M.

Seidlein LV.

In this Perspective article, Lorenz von Seidlein outlines the promise of two malaria vaccines, and discusses some of the considerations for their roll out.

Original publication

DOI

10.1371/journal.pmed.1004515

Type

Journal

PLoS medicine

Publication Date

01/2025

Volume

22

Addresses

Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Keywords

Humans, Plasmodium falciparum, Malaria, Malaria, Falciparum, Malaria Vaccines